REDWOOD CITY, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy to preserve sight for life in ...

Ixo-vec utilizes a proprietary vector capsid, AAV.7m8, carrying an aflibercept coding sequence under the control of a proprietary expression cassette and is designed to be administered as a one-time ...

Warning: this review contains full spoilers for Episode 3 of Daredevil: Born Again! The third episode of Daredevil: Born Again comes after a riveting two-part opener, so it’s understandable that ...

Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and improve vision outcomes for patients with wet AMD ARTEMIS ...

REDWOOD CITY, CA, USA I March 03, 2025 I Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy to preserve sight for life in highly prevalent ocular ...

NASA’s Petro Confident Of April 2026 Artemis II Launch Date is published in Aerospace Daily & Defense Report, an Aviation ...

NASA's next moon rocket is coming together, piece by piece. The core stage of NASA's next Space Launch System (SLS) rocket recently completed integration with the vehicle's side boosters inside ...

Based on Artemis Gold’s latest earnings release for the quarter ending September 30, the company reported a quarterly GAAP net loss of $10.3 million. In comparison, last year the company had a GAAP ...

The Space Launch System (SLS) core stage and rocket boosters have now been stood up and mated in preparation for NASA's Artemis 2 moon mission. On March 23, 2025, technicians working at NASA's ...